Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis reports positive data for Gilenya in key measures of MS disease activity
Novartis reports positive data for Gilenya in key measures of MS disease activity
Novartis reports positive data for Gilenya in key measures of MS disease activity
Submitted by
admin
on September 12, 2014 - 10:22am
Source:
First Word Pharma
News Tags:
Novartis
Gilenya
MS
multiple sclerosis
Headline:
Novartis reports positive data for Gilenya in key measures of MS disease activity
Do Not Allow Advertisers to Use My Personal information
